6-oxo-1,6-dihydropyridine compounds as inhibitors of MEK and methods of use thereof

Disclosed are compounds of the Formulas I and V and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8 and R9, W, X and Y are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and...

Full description

Saved in:
Bibliographic Details
Main Authors MARLOW ALLISON L, WALLACE ELI M, LYSSIKATOS JOSEPH P, BLAKE JAMES, YANG HONG-WOON, SEO JEONGBEOB
Format Patent
LanguageEnglish
Published 24.01.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are compounds of the Formulas I and V and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8 and R9, W, X and Y are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
Bibliography:Application Number: US20090577312